Correlation Between Spyre Therapeutics and DNBNO

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and DNBNO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and DNBNO into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and DNBNO 1535 25 MAY 27, you can compare the effects of market volatilities on Spyre Therapeutics and DNBNO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of DNBNO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and DNBNO.

Diversification Opportunities for Spyre Therapeutics and DNBNO

0.15

Correlation Coefficient

Spyre Therapeutics  DNBNO

Average diversification

The 3 months correlation between Spyre and DNBNO is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and DNBNO 1535 25 MAY 27 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DNBNO 1535 25 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with DNBNO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DNBNO 1535 25 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and DNBNO go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and DNBNO

Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 1.27 times more return on investment than DNBNO. However, Spyre Therapeutics is 1.27 times more volatile than DNBNO 1535 25 MAY 27. It trades about -0.12 of its potential returns per unit of risk. DNBNO 1535 25 MAY 27 is currently generating about -0.44 per unit of risk. If you would invest  2,681  in Spyre Therapeutics on October 9, 2024 and sell it today you would lose (239.00) from holding Spyre Therapeutics or give up 8.91% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	26.32%
Values	Daily Returns

Spyre Therapeutics  vs.  DNBNO 1535 25 MAY 27

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

DNBNO 1535 25

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DNBNO 1535 25 MAY 27 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for DNBNO 1535 25 MAY 27 investors.

Pair Trading with Spyre Therapeutics and DNBNO

The main advantage of trading using opposite Spyre Therapeutics and DNBNO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, DNBNO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DNBNO will offset losses from the drop in DNBNO's long position.

The idea behind Spyre Therapeutics and DNBNO 1535 25 MAY 27 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.